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A B S T R A C T
Objectives: Otitis media (OM) is one of the most frequent diseases of childhood, with a minority of
children suffering from recurrent acute otitis media (rAOM) or chronic otitis media with effusion
(COME), both of which are associated with signiﬁcant morbidity. We investigated whether the
microbiological proﬁling could be used to differentiate between these two conditions.
Methods: Children up to ﬁve years of age, with rAOM (n = 45) or COME (n = 129) and scheduled for
tympanostomy tube insertion were enrolled in a prospective study between 2008 and 2009. Middle ear
ﬂuids (n = 119) and nasopharyngeal samples (n = 173) were collected during surgery for bacterial culture
and PCR analysis to identify Streptococcus pneumoniae, Haemophilus inﬂuenzae and Moraxella catarrhalis,
and to detect 15 distinct respiratory viruses.
Results: The occurrence of bacterial and viral pathogens in middle ear ﬂuids did not signiﬁcantly differ
between patients suffering from rAOM and COME. In both patient cohorts, H. inﬂuenzae and rhinovirus
were the predominant pathogens in the middle ear and nasopharynx. Nasopharyngeal carriage with two
or three bacterial pathogens was associated with the presence of bacteria in middle ear ﬂuid (P = 0.04).
The great majority of the bacteria isolated from middle ear ﬂuid were genetically identical to
nasopharyngeal isolates from the same patient.
Conclusions: Based on these results, we propose that the common perception that rAOM is associated
with recurrent episodes of microbiologically mediated AOM, whereas COME is generally a sterile
inﬂammation, should be reconsidered.
 2012 Elsevier Ireland Ltd. 
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Otitis media (OM) is one of the most frequent diseases during
childhood and the most common reason for young children to visit
a physician. In many countries, it is the most common reason for
children to receive antibiotics or to undergo surgery [1–3].
OM is a common denominator for a variety of middle ear
diseases that can be divided into various categories, including
acute otitis media (AOM) and otitis media with effusion (OME) [4].
AOM is deﬁned as the presence of middle ear effusion accompanied* Corresponding author at: Department of Pediatrics, Radboud University
Medical Centre, P.O. Box 9101 (Internal Post 224), 6500 HB Nijmegen,
The Netherlands. Tel.: +31 24 3666407; fax: +31 24 3666352.
E-mail address: P.Hermans@cukz.umcn.nl (Peter W.M. Hermans).
1 These authors contributed equally to this study.
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Open access under the Elsevier OA license.by signs of acute inﬂammation of the middle ear, such as otalgia,
otorrhea, fever, and malaise or irritability of the child [3,5]. OME,
on the other hand, can either develop as a sequel to AOM, or
develop de novo, the primary symptom being hearing loss due to
the presence of middle ear ﬂuid in the middle ear cavity (but in the
absence of signs of acute inﬂammation) [6]. Albeit often self-
limiting, in 10–20% of the cases OM can result in chronic OME
(COME) or recurrent AOM (rAOM) disease [7].
Although there is currently no universal standard for OM
management, several options are available to the clinician,
namely: watchful waiting, antibiotic treatment, adenoidectomy,
ventilation tube insertion, or vaccination. AOM management
generally involves adequate analgesics with an optional observa-
tion period for 48–72 h [5]. Thereafter, antibiotic treatment or, in
the case of recurrent infections, antibiotic prophylaxis or ventila-
tion tube insertion are considered [5,8,9]. In contrast, for OME
disease, medical intervention is appropriate only if persistent
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resolution. Therefore, healthy children with OME are observed for
at least 3 months before medical intervention is considered, in
which case surgical treatment involving the insertion of ventila-
tion tubes or adenoidectomy is feasible [3,10]. Vaccination against
OM diseases is currently very limited, being directed against very
few bacterial OM pathogens, and only one of the viral OM
pathogens, i.e. the inﬂuenza vaccine. The heptavalent pneumococ-
cal conjugate vaccine is primarily directed against pneumococcal
invasive disease, whereas the introduction of vaccination only
reduced the overall OM incidence by 6–9% due to serotype or
pathogen replacement [11]. However, herd immunity may induce
a further decline in OM incidence, in line with nasopharyngeal
colonization studies 3 years after the introduction of the vaccine
[12,13].
A key element in the pathogenesis of OM is the nasopharynx, as
this niche is the reservoir for bacterial pathogens involved in
middle ear infections [4]. Colonization of the nasopharynx with
Streptococcus pneumoniae, Haemophilus inﬂuenzae or Moraxella
catarrhalis (the three most important bacterial pathogens associ-
ated with OM disease) at an early stage, has been shown to
predispose children for development of rAOM [14]. In addition,
OM-prone children have increased carriage rates of these bacterial
pathogens compared to healthy controls [15,16]. In AOM, S.
pneumoniae is the most frequently detected pathogen in middle
ear ﬂuid, followed by non-typeable H. inﬂuenzae and M. catarrhalis
[17–19]. However, H. inﬂuenzae tends to predominate in COME,
followed in a lesser extent by S. pneumoniae and M. catarrhalis [20].
In general, bacteria have been found less frequently in the middle
ear of children suffering from COME compared to AOM (approxi-
mately 30% versus 70%, respectively) [17].
In addition, many studies over the past decades have shown a
close association between AOM and respiratory viral infections
[21–24]. Viral upper respiratory tract infections (URI) predispose
children to AOM, as infection may cause Eustachian tube
dysfunction, and facilitate an increase in adherence of bacteria
to epithelial cells, resulting in a rise in bacterial colonization of the
nasopharynx and a modulation of the host’s immune function [25–
27]. Nevertheless, studies describing speciﬁc associations between
respiratory viruses and bacteria in rAOM and COME are scarce.
In this study, we investigated bacterial and viral colonization
and infection in the middle ear and nasopharynx of children
diagnosed with rAOM or COME. In particular, the contribution of 3
major bacterial pathogens (S. pneumoniae, H. inﬂuenzae and M.
catarrhalis) in the absence or presence of 15 distinct respiratory
viruses was studied in relation to rAOM and COME disease.
2. Materials and methods
2.1. Study design
A cohort of children up to ﬁve years of age who suffered from
rAOM or COME was examined in this prospective clinical study.
The cohort was enrolled at a secondary and a tertiary care hospital
in Nijmegen, the Netherlands, from April 1st 2008 to July 1st 2009,
and included children suffering from rAOM or COME who
underwent surgery for the insertion of ventilation tubes. Recurrent
AOM was deﬁned as 3 or more episodes of AOM in the last 6
months or 4 episodes in the last 12 months [28]. The COME patient
population consisted of children who had experienced a period of
persistent OM with effusion lasting longer than 3 months. RAOM or
COME diagnosis was made by an otolaryngologist in routine
clinical practice based upon signs, symptoms, otoscopy and
audiometry including tympanometry. Patients with a history of
malignancy, organ transplantation or immune deﬁciency were
excluded from participation, as well as patients with recentelective ear surgery or systemic infectious diseases. Children with
AOM and/or fever (T  38 8C) at the time of ventilation tube
insertion were rescheduled for the procedure. Adenoidectomy
performed in the same surgical setting was not considered to be an
exclusion criterion. Patient characteristics and risk factors were
acquired using a questionnaire, collected at the day of ventilation
tube insertion. Ethical permission was obtained from the
Committee on Research Involving Human Subjects in January
2008 (CMO 2007/239, international trial register number:
NCT00847756).
2.2. Clinical samples
Per child, one middle ear ﬂuid sample and one nasopharyngeal
sample was collected. Middle ear ﬂuid was collected during
surgery using a middle ear ﬂuid aspiration system (Kuijpers
Instruments, Groesbeek, The Netherlands) [29], nasopharyngeal
samples, taken through the nose, were obtained using a cotton
wool swab (192C, Copan, Brescia, Italy). Middle ear ﬂuid was
suspended in 2 ml saline and divided into aliquots for bacterial
culture, bacterial PCR, and viral multiplex PCR. The nasopharyngeal
samples were used for bacterial culture and thereafter stored at
80 8C in 1 ml of 80% glycerol for subsequent viral analysis.
2.3. Microbiology
Middle ear ﬂuid and nasopharyngeal samples were cultured
directly after collection according to standard laboratory proce-
dures [14] to determine the presence of S. pneumoniae, H.
inﬂuenzae and M. catarrhalis. Thereafter, bacteria were stored at
80 8C in appropriate media containing an additional 15% (S.
pneumoniae, H. inﬂuenzae) or 50% glycerol (M. catarrhalis). The less
frequently described otopathogens Staphylococcus aureus, Strepto-
coccus pyogenes, Haemophilus parainﬂuenzae, Pseudomonas aerugi-
nosa and Alloicoccus otitidis were also included in the analysis if
detected during bacterial culture.
To further characterize the bacterial isolates, all S. pneumoniae
and H. inﬂuenzae isolates were cultured overnight on, respectively,
blood agar and chocolate agar plates at 37 8C supplemented with
5% CO2. Pneumococcal isolates were serotyped using the Quellung
reaction (Statens Serum Institute, Copenhagen, Denmark) and
multiplex PCR as described previously [30]. H. inﬂuenzae isolates
were serotyped using slide agglutination according to the
manufacturer’s instructions (Becton–Dickinson, Breda, The
Netherlands) [31].
S. pneumoniae, H. inﬂuenzae or M. catarrhalis obtained from
middle ear ﬂuid, as well as the equivalent pathogen isolated from
the nasopharynx of the same patient, were further analyzed using
multilocus sequence typing (MLST). Genomic DNA was isolated
using a Qiagen Genomic-tip 20/G Kit (Venlo, The Netherlands)
according to the manufacturer’s instructions. DNA ampliﬁcation of
the MLST loci and sequencing was performed as described
previously [32–35]. Quantitative DNA analysis of S. pneumoniae,
H. inﬂuenzae and M. catarrhalis by real-time PCR was performed as
previously described. The respective genes chosen for bacterial
quantiﬁcation were the S. pneumoniae ply gene [36], H. inﬂuenzae
16S rRNA gene [37] and the M. catarrhalis ompJ gene [38].
2.4. Virology
Middle ear ﬂuid and nasopharyngeal samples were analyzed by
multiplex PCR as previously described [39]. Brieﬂy, upon thawing,
nucleic acids were extracted from each sample using the MagNA
Pure LC System and the MagNA Pure LC Total Nucleic Acid Isolation
Kit (Roche Applied Science, Almere, The Netherlands) according to
manufacturer’s instructions. A multiplex real-time PCR assay
Table 1
Characteristics of the pediatric study population.
rAOM n = 25
(%)
COME n = 94
(%)
P-value
Male sex 17/25 (69) 52/94 (55) 0.09
Mean age, years [SD] 3.3 [1.69] 4.02 [1.43] 0.10
<2 years of age 7 (28) 13 (14) 0.09
Presence of middle ear ﬂuid (MEF)a 25/25 (100) 94/94 (100) -
4 URTI in the preceding yearb 8/22 (36) 21/86 (24) 0.26
Recent antibiotic use 9/25 (36) 9/94 (10) <0.01
History of ENT surgery 8/18 (44) 37/67 (55) 0.42
Asthma/wheezing 2/23 (87) 7/87 (8) 0.92
Allergic rhinitis 2/22 (9) 4/86 (5) 0.42
Eczema 3/23 (13) 11/86 (13) 0.97
Birth weight, mean, (g, [SD]) 3291 [624] 3308 [791] 0.82
Breast feeding <3 months 15/23 (65) 51/87 (59) 0.57
PCV7 immunizationc 11/25 (44) 20/94 (21) 0.02
Tobacco smoke exposure 8/21 (38) 26/84 (31) 0.53
Older siblings 11/18 (61) 47/74 (64) 0.85
Day care attendance 10/22 (46) 40/84 (48) 0.86
Signiﬁcant differences are marked in bold.
a The MEF of 4 patients could not be collected for bacterial culture.
b Upper respiratory tract infections.
c The PCV7 vaccine was introduced in Dutch National Immunization Program for
children born after 01-04-2006.
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designed for the detection of the speciﬁc viral genomes of inﬂuenza
virus (IV) type A and B, coronavirus (CoV) 229E and OC43, human
bocavirus (hBoV), enterovirus (EV), adenovirus (AdV), parecho-
virus (PeV), parainﬂuenza virus (PIV) types 1–4, human metap-
neumovirus (hMPV), rhinovirus (RV) and respiratory syncytial
virus (RSV). An internal control consisting of phocine herpesvirus
(PhPV, IC DNA control) and equine arthritis virus (EAV, IC RNA
control) was included in the assay. RNA was reverse transcribed to
cDNA using the TaqMan Reverse Transcription Reagents kit
(Applied Biosystems, Nieuwekerk aan de IJssel, The Netherlands)
in a 50 ml reaction mix containing 20 ml of nucleic acid isolate and
random hexamers as primers (2.5 mM), according to the manu-
facturer’s instructions. PCRs were performed on the LightCycler
480 instrument using LightCycler 480 Probes Master Mix (Roche
Diagnostics). Validated primer/probe-mixes were purchased from
Diagenode (Lie`ge, Belgium) and used according to the manufac-
turer’s instructions. Cycling conditions were 95 8C for 5 min,
followed by 50 cycles of 95 8C for 15 s and 55 8C for 15 s and 72 8C
for 20 s.
2.5. Statistical analysis
Statistical analyses were performed using the Statistical
Package of Social Sciences version 17.0 (SPSS Inc., Chicago, IL,
USA). The chi-square test or Mann–Whitney U-test was used when
appropriate to calculate the statistical differences between patient
baseline characteristics. The chi-square test was used in the
analysis of categorical data obtained from bacterial culture,
bacterial PCR and viral PCR. A P-value <0.05 was considered
statistically signiﬁcant.
3. Results
3.1. rAOM and COME cannot be differentiated based on bacterial
infection
A total of 176 children were enrolled in the study (age range
0.6–5.9 years). Selected demographic and clinical characteristics of
the cohort are shown in Table 1. Recurrent AOM was mostly
diagnosed at a younger age, while the prevalence of COME
increased with age (rAOM 75% during the ﬁrst year of life vs. 17% at
5 years of age; COME 25% during the ﬁrst year of life vs. 83% at 5
years of age). A middle ear ﬂuid specimen was collected from 69%
of the children (n = 119), with a signiﬁcant difference in the
presence of middle ear ﬂuid and OM diagnosis (rAOM n = 26 (58%)
vs. COME n = 97 (75%), P = 0.02). Children suffering from rAOM
presented with less ENT-related surgery in their medical history
when compared to children suffering from COME, but received
signiﬁcantly more antibiotics in the year prior to surgery.
3.2. Microbial proﬁling does not differentiate between rAOM and
COME
The frequency of S. pneumoniae, H. inﬂuenzae and M. catarrhalis
in middle ear ﬂuid and the nasopharynx is shown in Table 2. InTable 2
Frequency of S. pneumoniae, H. inﬂuenzae and M. catarrhalis in middle ear ﬂuid (MEF) a
Bacterial culture MEF Bacte
rAOM n = 25 COME n = 94 rAOM
No bacteria, n (%) 18 (72) 64 (68) 9 (3
S. pneumoniae, n (%) 0 (0) 5 (5) 3 (1
H. inﬂuenzae, n (%) 6 (24) 18 (19) 10 (4
M. catarrhalis, n (%) 1 (4) 9 (10) 7 (2
a MEF positive patients only.total, 117 samples were screened for bacterial presence by both,
bacterial culture and PCR. Not surprisingly, PCR detected bacterial
DNA in a statistically signiﬁcant percentage of culture-negative
middle ear effusions: S. pneumoniae in 4.1% (NS), H. inﬂuenzae in
16.5% (P < 0.01) and M. catarrhalis in 19% (P < 0.01).
Importantly, the presence of each speciﬁc pathogen, measured
using conventional culture techniques or PCR, was not signiﬁcantly
different between the rAOM and COME cohorts (Table 2).
3.3. The presence of multiple bacterial species of middle ear ﬂuid was
sporadic
The presence of multiple bacterial species within middle ear
ﬂuids (based on bacterial culture) was sporadic: co-infection by S.
pneumoniae and H. inﬂuenzae was observed in a single patient only,
as was co-infection by H. inﬂuenzae and M. catarrhalis.
Based on the PCR results, the presence of multiple bacterial
pathogens was sporadic and similar in rAOM (10%) and COME (15%).
In rAOM S. pneumoniae and M. catarrhalis were both detetected in 1
child (4%), H. inﬂuenzae and M. catarrhalis in 2 children (8%), and all 3
pathogens in 1 child (4%). In children suffering from COME, S.
pneumoniae and M. catarrhalis were both detected in 3 children (3%),
M. catarrhalis and H. inﬂuenzae in 5 children (5%), and S. pneumoniae
and H. inﬂuenzae in 2 children (2%).
3.4. Bacterial nasopharyngeal carriage is associated with bacterial
presence in the middle ear
H. inﬂuenzae was the most frequently detected bacterial
pathogen in the nasopharynx and was equally present in both
the rAOM and COME cohort (68% versus 70%, respectively, Table 2).
Colonization of the nasopharynx by S. pneumoniae occurred in 44%nd the nasopharynx of children suffering from rAOM and COME.
rial PCR MEF Bacterial culture nasopharynx
 n = 24 COME n = 93 rAOM n = 25a COME n = 94a
8) 45 (48) 2 (8) 9 (10)
3) 6 (7) 11 (44) 57 (61)
2) 30 (32) 17 (68) 66 (70)
9) 22 (24) 12 (48) 40 (43)
Table 3
Presence of viruses in middle ear ﬂuid and the nasopharynx of children suffering
from rAOM and COME.
Middle ear ﬂuid Nasopharynx
rAOM
n = 25 (%)
COME
n = 86b (%)
rAOMa
n = 22c (%)
COMEa
n = 81c (%)
No viruses detected, n (%) 10 (40) 40 (47) 5 (23) 23 (28)
Rhinovirus, n (%) 11 (44) 38 (44) 11 (50) 43 (53)
Enterovirus, n (%) 2 (8) 7 (8) 5 (23) 6 (7)
Coronavirus, n (%) 2 (8) 2 (2) 1 (5) 3 (4)
Parainﬂuenzavirus, 1–4, n (%) 1 (4) 1 (1) 2 (9) 8 (10)
Others, n (%)d 0 (0) 7 (8) 4 (18) 15 (19)
Signiﬁcant differences are shown in bold. P = 0.04.
a MEF positive patients.
b The MEF of 8 COME patients could not be collected for viral PCR.
c The nasopharyngeal swab of respectively 3 rAOM and 13 COME patients could
not be used for viral PCR.
d Adenovirus, inﬂuenzavirus type A and B, hMPV, hPeV, hBV, RSV.
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catarrhalis was detected in the nasopharynx of 48% of the rAOM
and 43% of the COME patients. Eight percent and 10% of the
children were culture negative for nasopharyngeal carriage in
rAOM and COME disease, respectively (Table 2). Of note, co-
colonization of two or more bacterial pathogens in the nasophar-
ynx was signiﬁcantly associated with the presence of bacteria in
middle ear ﬂuid (P = 0.04).
3.5. Bacteria in the nasopharynx and middle ear are often genetically
identical
The presence of S. pneumoniae or H. inﬂuenzae in middle ear
ﬂuid correlated positively with the presence of the same species in
the nasopharynx (S. pneumoniae, P = 0.05; H. inﬂuenzae, P = 0.04).
M. catarrhalis was found in the nasopharynx of 42% of the children,
with simultaneous occurrence of M. catarrhalis in the middle ear in
8% of the children; this latter association was not signiﬁcant.
Serotype analysis of the 5 S. pneumoniae isolates cultured from
middle ear ﬂuid revealed the following serotypes: 23A (n = 1), 23F
(n = 1), 6B (n = 1), 19A (n = 1) and 7F (n = 1). In all cases, the
corresponding serotype was also found in the nasopharynx. No
statistically signiﬁcant differences were observed between the 68
nasopharyngeal S. pneumoniae isolates, regarding pneumococcal
vaccine types (i.e. those present in heptavalent Pneumococcal
Conjugate Vaccine) and non-vaccine types (NVT, rAOM 72%;
COME, 69%), nor between typeable and non-typeable (NT)
pneumococcal strains (NT: rAOM 9%; COME 2%) when comparing
rAOM and COME cohorts.
Twenty-two of the H. inﬂuenzae isolates cultured from the
middle ear were non-typeable (rAOM 83%; COME 100%), compared
to 80 non-typeable isolates cultured from the nasopharynx (rAOM
95%; COME 94%). Serotype E was detected in 4% of the middle ear
ﬂuid and 4% of the nasopharynx specimens. Serotype B was
detected in 1 nasopharyngeal specimen.
MLST analysis revealed that the majority of nasopharyngeal and
middle ear ﬂuid isolates obtained from the same child were
genetically identical (S. pneumoniae and M. catarrhalis 100%; H.
inﬂuenzae 80%). Further, no clonal relationships were observed for
any of the 3 bacterial pathogens, i.e. there was no evidence to
suggest that isolates originated from a single ‘‘founder’’ isolate
spreading throughout the community when the respective isolates
were compared to their pathogen-speciﬁc databases.
3.6. Rhinovirus dominates in both rAOM and COME and contributes to
bacterial colonization
Rhinovirus was the most frequently detected virus in middle
ear ﬂuids in both patient cohorts, followed by enterovirus,
coronavirus and parainﬂuenza viruses (Table 3). The presence of
enterovirus in middle ear ﬂuids was associated with the presence
of rhinovirus, as 8 out of the 9 enterovirus-positive middle ears
were also positive for rhinovirus (P = 0.01). Nevertheless, in the
vast majority of the virus-positive samples only a single virus was
detected.
Rhinovirus was also the most frequently detected virus in the
nasopharynx, followed by enterovirus, parainﬂuenza viruses 1–4
and coronavirus (Table 3). Nasopharyngeal colonization with
enterovirus was signiﬁcantly more frequent in rAOM patients than
in COME patients (P = 0.04). In contrast to the results obtained
from middle ear ﬂuids, no association between rhinovirus and
enterovirus could be found in the nasopharynx. Similar to middle
ear ﬂuid, in the majority of the virus-positive nasopharyngeal
samples only a single virus was detected (74%).
Interestingly, a signiﬁcant association was observed for
bacterial-viral co-occurrence in the nasopharynx. In more detail,the presence of a virus was accompanied by the presence of a
bacterium in 92% of the virus positive nasopharyngeal samples,
whereas virus was present in 74% of the bacterial positive
nasopharyngeal samples (P = 0.02). More speciﬁcally, the presence
of S. pneumoniae and H. inﬂuenzae was signiﬁcantly associated with
the presence of rhinovirus (P = 0.05 and P < 0.01, respectively), and
the presence of M. catarrhalis was signiﬁcantly associated with the
presence of enterovirus (P = 0.02). However, no signiﬁcant differ-
ence in bacterial-viral co-colonization of the nasopharynx was
detected between children with rAOM or COME.
4. Discussion
In this prospective study, we investigated whether the clinical
signs and symptoms speciﬁc for rAOM and COME could be
microbiologically differentiated by the presence of bacteria and
viruses in middle ear ﬂuid. The results of our study show that the
most predominant bacterial pathogen associated with middle ear
ﬂuids obtained from children suffering from rAOM and COME is
non-typeable H. inﬂuenzae, and that the presence of S. pneumoniae,
H. inﬂuenzae or M. catarrhalis is not signiﬁcantly different between
children with rAOM or COME. With respect to the nasopharynx
(and similar to the results obtained using middle ear ﬂuids), the
most frequent bacterial pathogen detected within both patient
cohorts was non-typeable H. inﬂuenzae. The predominance of H.
inﬂuenzae in the middle ear and nasopharynx of rAOM and COME
patients is similar to other otitis media studies performed
elsewhere [40,41].
MLST analysis of the isolates indicated that the pathogens
present in the nasopharynx and middle ear were genetically
identical within the same child. The S. pneumoniae, H. inﬂuenzae
and M. catarrhalis genotypes isolated from the total cohort of
children comprised a genetically heterogeneous population
structure, i.e. the isolates were genetically highly diverse, even
though they all originated from a relatively restricted geographical
region of The Netherlands. Importantly, the bacterial pathogens
that were detected in the middle ear ﬂuids of our cohorts tended to
be genetically identical (using MLST) to those isolates cultured
from the nasopharynx (80–100%), a ﬁnding that correlates with
previously published data. Studies investigating the genetic
relatedness of bacteria obtained from different locations of the
upper respiratory tract, and within a single patient are scarce.
Various approaches to determine the genetic relatedness of
nasopharyngeal and OM isolates have been described, however
MLST was only used once, a technique that is considered to be the
gold standard regarding bacterial genotyping [42–44].
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[45,46] and showed to be the most frequently found virus in the
nasopharynx and middle ear of both COME and rAOM patients.
Co-infection of rhinovirus and enterovirus was found in the
middle ear, but not in the nasopharynx. Co-occurrence of these
viruses has been previously described by Rezes et al., who found
rhinovirus in middle ear ﬂuid in 4.8% of the 17 children,
enterovirus in 23.8% and both rhino- and enterovirus in 14.3%
[46]. Nevertheless, in our study the co-occurrence of multiple
viruses in middle ear ﬂuid or in the nasopharynx was rare. In the
nasopharynx of our OM patients we found a single virus in 46%
and 2 viruses in 9%, in contrast to healthy children as described
by Bogaert et al. [47]. They found two or more viruses in the
majority of the virus positive nasopharyngeal samples, in 96
children up to two years of age [47]. In our cohort only 15% of the
children under the age of 2 had maximal two viruses in the
nasopharynx. This ﬁnding suggests that in symptomatic children
suffering from OM one virus is predominant in the nasopharynx,
whereas in healthy children more viruses can be present without
clinical signiﬁcance.
The ability of upper respiratory tract viruses to facilitate
secondary bacterial infection in AOM has been described
extensively in the literature [27,48,49]. Inﬂuenza A and S.
pneumoniae, RSV and H. inﬂuenzae are two examples of viral-
bacterial interaction investigated in both animal models and
human studies [50]. To our knowledge this is the ﬁrst report
describing a highly signiﬁcant association for the co-occurrence of
bacteria and virus in the nasopharynx of rAOM and COME patients.
More speciﬁcally, nasopharyngeal co-colonization of rhinoviruses
with either S. pneumoniae, or H. inﬂuenzae, was statistically
signiﬁcant. Pitkaranta et al. observed a positive correlation
between the presence of S. pneumoniae or M. catarrhalis and
rhinovirus in the nasopharynx, but not of H. inﬂuenzae and
rhinovirus [45]. However, the authors focused on nasopharyngeal
samples of OM-prone children, and exclusion criteria for their
study were either recent or expected ventilation tube insertion and
COME diagnosis [45]. In the present study, no association between
the co-occurrence of these viruses and bacteria was observed in
middle ear ﬂuids for both rAOM and COME cohorts, likely caused
by the relatively low number of bacteria detected in middle ear
ﬂuid. In addition, since viruses can predispose to bacterial super-
infection, it is possible that they are already cleared from the
middle ear cavity at the time of surgery.
There are a few limitations of this study. First, the number of
children with rAOM enrolled in this study is limited. Second,
although we used internationally accepted deﬁnitions for rAOM
and COME, the timing of clinical sampling in relation to the exact
onset of OM is unknown. Finally, while bacteria can colonize and
persist in the human respiratory tract for months, infection with
respiratory viruses results in acute viral replication, which is
cleared within days to weeks. As a consequence, the persistence of
bacterial DNA probably exceeds that of viruses.
In conclusion, we performed a prospective cohort study to
investigate the frequency and types of bacterial and viral
pathogens in the middle ear and nasopharynx of children
suffering from rAOM or COME. Our results show that the same
pathogenic bacterial species and viruses are implicated in the
pathogenesis of both rAOM and COME disease. Further, our
ﬁndings do not support the general assumption that the microbial
proﬁle is pathognomonic for either rAOM or COME, or that COME
is merely a consequence of persistent sterile inﬂammation in the
middle ear.
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